Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology-Basic: Translational/Preclinical Nuclear Medicine

Pre-clinical assessment of phosphokinase activity by an anti-phosphor-tyrosine antibody labeled with In-111

Saady Kohanim, Richard Mendez, Chang-Sok Oh, Mithu Chanda, DongFang Yu and David Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1190;
Saady Kohanim
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Mendez
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang-Sok Oh
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mithu Chanda
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DongFang Yu
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Yang
1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 1190

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Saady Kohanim1,
  2. Richard Mendez1,
  3. Chang-Sok Oh1,
  4. Mithu Chanda1,
  5. DongFang Yu1 and
  6. David Yang1
  1. 1Experimental Diagnostic Imaging, UT-MD Anderson Cancer Center, Houston, TX

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Dec 2014100
Jan 2015100
May 2015100
Jun 2015200
Aug 2015300
Sep 2015600
Jan 2016100
Jun 2016200
Jul 2016100
Aug 2016100
Sep 2016100
Oct 2016100
Nov 2016100
Dec 2016300
Jan 2017400
Feb 2017400
Mar 2017100
Apr 2017300
May 2017200
Jun 2017200
Jul 2017500
Aug 2017200
Sep 2017300
Oct 2017500
Nov 2017200
Apr 2018300
May 2018100
Sep 2018300
Nov 2018100
Mar 2019100
Apr 2019100
May 2019100
Jun 2019100
Jul 2019600
Aug 2019100
Sep 2019400
Oct 2019100
Dec 2019200
Jan 2020300
May 2020100
Aug 2020400
Sep 2020200
Oct 2020200
Dec 2020100
Feb 2021700
Mar 20211200
Apr 20211000
May 2021700
Jun 2021400
Jul 2021600
Aug 2021500
Sep 2021200
Oct 2021200
Nov 2021100
Dec 2021400
Jan 2022200
Feb 2022300
Mar 2022300
Apr 20221200
May 2022700
Jun 2022300
Aug 2022100
Oct 2022100
Dec 2022200
Feb 2023400
Mar 2023400
Apr 2023500
May 2023500
Jun 2023400
Jul 2023400
Aug 2023900
Sep 2023700
Oct 2023800
Nov 2023300
Dec 2023400
Jan 2024400
Feb 2024100
Mar 2024300
Apr 2024300
May 2024200
Jun 2024200
Aug 2024800
Sep 2024900
Oct 2024200
Nov 2024100
Dec 2024700
Jan 2025100
Mar 2025200
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pre-clinical assessment of phosphokinase activity by an anti-phosphor-tyrosine antibody labeled with In-111
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pre-clinical assessment of phosphokinase activity by an anti-phosphor-tyrosine antibody labeled with In-111
Saady Kohanim, Richard Mendez, Chang-Sok Oh, Mithu Chanda, DongFang Yu, David Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1190;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pre-clinical assessment of phosphokinase activity by an anti-phosphor-tyrosine antibody labeled with In-111
Saady Kohanim, Richard Mendez, Chang-Sok Oh, Mithu Chanda, DongFang Yu, David Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1190;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology-Basic: Translational/Preclinical Nuclear Medicine

  • Novel 18F-labeled peptides for GRP and NPY1 receptor imaging in prostate and breast cancer models by PET
  • Optimization of MORAb-009 dose to block shed antigen in circulation and produce high tumor to background ratios of In-111 MORAb-009
  • Novel knottin miniproteins for tumor angiogenesis targeting
Show more Oncology-Basic: Translational/Preclinical Nuclear Medicine

Oncology: Translational/Preclinical Nuclear Medicine Posters

  • Novel 18F-labeled peptides for GRP and NPY1 receptor imaging in prostate and breast cancer models by PET
  • Optimization of MORAb-009 dose to block shed antigen in circulation and produce high tumor to background ratios of In-111 MORAb-009
  • Novel knottin miniproteins for tumor angiogenesis targeting
Show more Oncology: Translational/Preclinical Nuclear Medicine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire